Relative Bioavailability of BI 10773 and Simvastatin After Single and Combined Administration - an Open-label, Randomised, Crossover Trial in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Empagliflozin (Primary) ; Simvastatin
- Indications Diabetic cardiomyopathy; Hypercholesterolaemia; Low HDL cholesterol; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 07 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2011 New trial record